BEAM Biotech & Pharm Company R&D Data

Overview

Make more informed decisions to mitigate risk by leveraging pharmaceutical data. Unlock the biotech and pharmaceutical R&D landscape to power predictive analytics with access to over 20 years of model-ready clinical trial data.

Assess pipeline strength and determine ability to win using point-in-time clinical trial data including more than 1,800 ticker symbols mapped to public companies in the pharmaceutical and healthcare industry.

Predict likelihood of success, timing, and value impact of company trials with our proprietary data elements for biomarkers, novel status, endpoints and mechanism of action to support your predictive analytics.

Data Feed Coverage

Data Feed Details

BEAM Data contains over 130,000 industry-sponsored clinical trials, covering more than 1,00,000 point-in-time data versions, across 6,000 companies with over 1,800 mapped to ticker symbols. The robust point-in-time data includes cleaned company names, drug names, Mechanism of Action, drug target information, FDA approved or novel status, disease area tags, oncology biomarkers and various text rich data elements for NLP development of categories and indicators. Additionally, the data provides performance prediction flags to better predict clinical trial success. The data also offers elements to predict stock price performance related to trial completion and stock price performance within the first 28 days after the start of a trial.

Firm Information

OZMOSI ( https://www.ozmosi.com/ ) is a consulting and data services firm founded in 2013 with the singular mission to provide pharmaceutical and biotechnology companies the support they need to make hard decisions in a high-risk and highly uncertain environment. Combining expert pharmaceutical experience with advanced analytics, OZMOSI offers state-of-the-art modeling, machine learning and visualization tools, illuminating the competitive landscape without sacrificing any of the details.